The EPS projection of Itron, Inc. (NASDAQ:ITRI) for quarter ended 2016-06-30 is $0.49. Last week, the EPS forecast was $0.49 against target of $0.49, a month earlier. Two months ago, this estimate was $0.49 versus forecast of $0.49 three months earlier, implying a deviation of 0%.
Itron, Inc. (NASDAQ:ITRI) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Itron, Inc. (NASDAQ:ITRI) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
Itron, Inc. (NASDAQ:ITRI) EPS target for the quarter closed 4 was $0.49, based on 6 recommendations. As reported on 2016-02-17 the EPS was $0.77. The change was $0.05, implying a percentage deviation of 6.94%. The projections showed a standard deviation of 0.08.
Quarterly Sales Estimates
Itron, Inc. (NASDAQ:ITRI) yearly sales prediction for the fiscal 2016 stands at $504.702 and the median estimate is at $499.4. Almost 4 analysts issued sales target.
Highest sales target is $529.908 while the lowest target is $490.1 showing standard deviation of 17.373%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Itron, Inc. (NASDAQ:ITRI) announced that the deviation in forecast was -0.525%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...